EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica.

EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica.

Show other versions (1)

Cutaneous Leishmaniasis (CL) is a parasitic infection classified by the WHO as one of the most uncontrolled spreading neglected diseases. Syria is endemic for Leishmania tropica and Leishmania major, causing CL in the Eastern Mediterranean. The large-scale displacement of Syrian refugees exacerbated...

Full description

Bibliographic Details
Main Authors: Rana El Hajj, Hanady Bou Youness, Laurence Lachaud, Patrick Bastien, Carine Masquefa, Pierre-Antoine Bonnet, Hiba El Hajj, Ibrahim Khalifeh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-11-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC6248897?pdf=render

Internet

http://europepmc.org/articles/PMC6248897?pdf=render

Similar Items